Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Receptor for Hyaluronan-Mediated Motility Correlates with Centrosome Abnormalities in Multiple Myeloma and Maintains Mitotic Integrity

1 Feb 2005

Abstract excerpt

Elevated expression of receptor for hyaluronan-mediated motility (RHAMM) within ex vivo diagnostic multiple myeloma plasma cells predicts for aggressive disease and patient survival. Here, we investigate the relationship between RHAMM and centrosomal abnormalities within multiple myeloma patient samples. We report that myeloma patient samples contain pervasive structural and numerical centrosomal abnormalities....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Microtubule and mitosis dynamics
Share to Multiple Myeloma Research and Treatments
Share to Protein Degradation and Inhibitors

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 15705883
DOI: 10.1158/0008-5472.850.65.3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Receptor for Hyaluronan-Mediated Motility Correlates with Centrosome Abnormalities in Multiple Myeloma and Maintains Mitotic IntegrityPMID 15705883Read ↗

Overexpression of the Receptor for Hyaluronan-Mediated Motility (RHAMM) Characterizes the Malignant Clone in Multiple Myeloma: Identification of Three Distinct RHAMM VariantsSemantic proximity Read ↗

RHAMM expression and isoform balance predict aggressive disease and poor survival in multiple myelomaSemantic proximity Read ↗

Aurora A kinase RNAi and small molecule inhibition of Aurora kinases with VE-465 induce apoptotic death in multiple myeloma cellsSemantic proximity Read ↗

Citron Rho-interacting kinase silencing causes cytokinesis failure and reduces tumor growth in multiple myelomaSemantic proximity Read ↗

DIS3 depletion in multiple myeloma causes extensive perturbation in cell cycle progression and centrosome amplificationSemantic proximity Read ↗

The centrosome index is a powerful prognostic marker in myeloma and identifies a cohort of patients that might benefit from aurora kinase inhibitionSemantic proximity Read ↗

Receptor for Hyaluronan-Mediated Motility (RHAMM) defines an invasive niche associated with tumor progression and predicts poor outcomes in breast cancer patientsSemantic proximity Read ↗

In vitro reconstitution of minimal human centrosomesSemantic proximity Read ↗

SAE1 promotes tumor cell malignancy via SUMOylation and liquid–liquid phase separation facilitated nuclear export of p27Semantic proximity Read ↗

The hyaluronan receptor RHAMM regulates extracellular-regulated kinase.Semantic proximity Read ↗

NEK2 induces osteoclast differentiation and bone destruction via heparanase in multiple myelomaSemantic proximity Read ↗

Heparanase promotes myeloma progression by inducing mesenchymal features and motility of myeloma cells.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.